Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-04-11 Sale | 2024-04-15 6:27 pm | Disc Medicine Inc. | IRON | White William Richard Director | 2,560 | $31.8 | $81,407 | 8,680 (Direct) | View |
| 2024-03-13 Sale | 2024-03-15 4:44 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 724 | $28.33 | $20,511 | 49,630 (Direct) | View |
| 2023-12-14 Sale | 2023-12-18 8:40 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 611 | $20.76 | $12,684 | 50,354 (Direct) | View |
| 2023-12-12 Sale | 2023-12-14 4:15 pm | Disc Medicine Inc. | IRON | White William Richard Director | 33,511 | $63.21 | $2,118,239 | 11,240 (Direct) | View |
| 2023-09-13 Sale | 2023-09-25 8:31 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 632 | $50.34 | $31,815 | 18,468 (Direct) | View |
| 2023-06-20 Sale | 2023-06-22 5:20 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 20,777 | $55 | $1,142,735 | 243,429 (Direct) | View |
| 2023-06-13 Sale | 2023-06-15 9:41 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 606 | $55.16 | $33,427 | 22,377 (Direct) | View |
| 2023-01-23 Sale | 2023-01-24 6:33 pm | Ventyx Biosciences Inc. | VTYX | White William Richard Director | 33,353 | $35.1 | $1,170,592 | 119,120 (Direct) | View |
| 2022-12-27 Sale | 2022-12-29 5:41 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 20,000 | $49.77 | $995,323 | 508,281 (Direct) | View |
| 2022-10-13 Sale | 2022-10-17 5:40 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 20,000 | $39.82 | $796,400 | 266,258 (Direct) | View |
| 2022-09-13 Sale | 2022-09-15 7:57 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 32,500 | $27.03 | $878,341 | 286,258 (Direct) | View |
| 2022-01-14 Sale | 2022-01-18 9:48 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 9,700 | $22.03 | $213,691 | 317,606 (Direct) | View |
| 2021-12-21 Sale | 2021-12-23 9:03 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 100 | $22 | $2,200 | 327,306 (Direct) | View |
| 2021-12-17 Sale | 2021-12-20 4:54 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 3,200 | $22.04 | $70,528 | 327,406 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 4:15 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $22.24 | $144,560 | 330,606 (Direct) | View |
| 2021-10-01 Sale | 2021-10-05 4:10 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $22.06 | $143,367 | 337,106 (Direct) | View |
| 2021-09-01 Sale | 2021-09-03 4:38 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 8,559 | $24 | $205,416 | 343,606 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 5:39 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 4,441 | $22.03 | $97,835 | 352,165 (Direct) | View |
| 2021-07-06 Sale | 2021-07-08 7:19 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $24.52 | $159,380 | 356,606 (Direct) | View |
| 2021-05-03 Sale | 2021-05-04 4:06 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 4,200 | $30.56 | $128,352 | 362,099 (Direct) | View |
| 2021-04-01 Sale | 2021-04-05 5:14 pm | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 50,000 | $28.64 | $1,432,166 | 366,299 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-04-11 Exercise | 2024-04-15 6:27 pm | N/A N/A | Disc Medicine Inc. | IRON | White William Richard Director | 1,756 | $2.65 | 8,680 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 6:27 pm | N/A N/A | Disc Medicine Inc. | IRON | White William Richard Director | 804 | $9.86 | 8,680 (Direct) | View |
| 2024-04-11 Exercise | 2024-04-15 6:27 pm | N/A 2030-11-26 | Disc Medicine Inc. | IRON | White William Richard Director | 2,560 | $0 | 8,680 (Direct) | View |
| 2024-01-21 Option Award | 2024-01-23 5:23 pm | N/A 2034-01-21 | Ventyx Biosciences Inc. | VTYX | White William Richard Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 4:15 pm | N/A N/A | Disc Medicine Inc. | IRON | White William Richard Director | 21,084 | $2.65 | 11,240 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 4:15 pm | N/A N/A | Disc Medicine Inc. | IRON | White William Richard Director | 5,427 | $9.86 | 11,240 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 4:15 pm | N/A N/A | Disc Medicine Inc. | IRON | White William Richard Director | 7,000 | $13.5 | 11,240 (Direct) | View |
| 2023-12-12 Exercise | 2023-12-14 4:15 pm | N/A 2030-11-26 | Disc Medicine Inc. | IRON | White William Richard Director | 33,511 | $0 | 11,240 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 4:43 pm | N/A 2033-12-07 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 178,734 | $0 | 197,202 (Direct) | View |
| 2023-11-09 Option Award | 2023-11-13 5:37 pm | N/A 2033-11-08 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 83,400 | $0 | 83,400 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 5:20 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 17,500 | $7.009 | 243,429 (Direct) | View |
| 2023-06-20 Exercise | 2023-06-22 5:20 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 17,500 | $0 | 243,429 (Direct) | View |
| 2023-06-08 Option Award | 2023-06-12 4:45 pm | N/A 2033-06-08 | Ventyx Biosciences Inc. | VTYX | White William Richard Director | 15,937 | $0 | 15,937 (Direct) | View |
| 2023-06-09 Option Award | 2023-06-09 6:16 pm | N/A 2033-06-08 | Disc Medicine Inc. | IRON | White William Richard Director | 7,136 | $0 | 7,136 (Direct) | View |
| 2022-06-09 Option Award(A) | 2023-04-26 8:27 pm | N/A 2032-06-09 | Ventyx Biosciences Inc. | VTYX | White William Richard Director | 21,825 | $0 | 21,825 (Direct) | View |
| 2023-03-10 Tax Withholding | 2023-03-14 4:25 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 641 | $43.47 | 22,983 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-24 6:33 pm | N/A N/A | Ventyx Biosciences Inc. | VTYX | White William Richard Director | 33,353 | $6.03 | 119,120 (Direct) | View |
| 2023-01-23 Exercise | 2023-01-24 6:33 pm | N/A 2031-08-17 | Ventyx Biosciences Inc. | VTYX | White William Richard Director | 33,353 | $0 | 119,120 (Direct) | View |
| 2022-12-29 Option Award | 2023-01-03 5:05 pm | N/A 2032-12-28 | Disc Medicine Inc. | IRON | White William Richard Director | 7,000 | $0 | 7,000 (Direct) | View |
Ownership | 2023-01-03 5:00 pm | N/A 2030-11-26 | Disc Medicine Inc. | IRON | White William Richard Director | 0 | $0 | 37,751 (Direct) | View |
| 2022-12-27 Exercise | 2022-12-29 5:41 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 20,000 | $7.009 | 508,281 (Direct) | View |
| 2022-12-27 Exercise | 2022-12-29 5:41 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 20,000 | $0 | 508,281 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 7:49 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 29,073 | $0 | 87,221 (Direct) | View |
| 2022-12-09 Option Award | 2022-12-13 8:28 pm | N/A 2032-12-08 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 105,574 | $0 | 110,003 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 5:40 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 20,000 | $7.009 | 266,258 (Direct) | View |
| 2022-10-13 Exercise | 2022-10-17 5:40 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 20,000 | $0 | 266,258 (Direct) | View |
| 2022-09-13 Exercise | 2022-09-15 7:57 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 32,500 | $7.009 | 286,258 (Direct) | View |
| 2022-09-13 Exercise | 2022-09-15 7:57 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 32,500 | $0 | 286,258 (Direct) | View |
| 2022-09-09 Option Award | 2022-09-13 9:14 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 58,148 | $0 | 91,651 (Direct) | View |
| 2022-06-30 Option Award | 2022-09-13 9:14 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 1,152 | $8.03 | 91,651 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 5:41 pm | N/A 2032-06-09 | Ventyx Biosciences Inc. | VTYX | White William Richard Director | 13,301 | $0 | 13,301 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-18 9:48 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 9,700 | $7.009 | 317,606 (Direct) | View |
| 2022-01-14 Exercise | 2022-01-18 9:48 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 9,700 | $0 | 317,606 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 9:03 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 100 | $7.009 | 327,306 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 9:03 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 100 | $0 | 327,306 (Direct) | View |
| 2021-12-17 Exercise | 2021-12-20 4:54 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 3,200 | $7.009 | 327,406 (Direct) | View |
| 2021-12-17 Exercise | 2021-12-20 4:54 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 3,200 | $0 | 327,406 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 5:08 pm | N/A 2031-12-07 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 87,221 | $0 | 87,221 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 4:15 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $7.009 | 330,606 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 4:15 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $0 | 330,606 (Direct) | View |
Ownership | 2021-10-20 6:48 pm | N/A 2031-08-17 | Ventyx Biosciences Inc. | VTYX | White William Richard Director | 0 | $0 | 152,473 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-05 4:10 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $7.009 | 337,106 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-05 4:10 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $0 | 337,106 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-03 4:38 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 8,559 | $7.009 | 343,606 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-03 4:38 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 8,559 | $0 | 343,606 (Direct) | View |
| 2021-08-02 Exercise | 2021-08-04 5:39 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 4,441 | $7.009 | 352,165 (Direct) | View |
| 2021-08-02 Exercise | 2021-08-04 5:39 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 4,441 | $0 | 352,165 (Direct) | View |
| 2021-07-06 Exercise | 2021-07-08 7:19 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $7.009 | 356,606 (Direct) | View |
| 2021-07-06 Exercise | 2021-07-08 7:19 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 6,500 | $0 | 356,606 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-04 4:06 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 4,200 | $7.009 | 362,099 (Direct) | View |
| 2021-05-03 Exercise | 2021-05-04 4:06 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 4,200 | $0 | 362,099 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-05 5:14 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 50,000 | $7.01 | 366,299 (Direct) | View |
| 2021-04-01 Exercise | 2021-04-05 5:14 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 50,000 | $0 | 366,299 (Direct) | View |
| 2020-12-08 Option Award | 2020-12-09 8:52 pm | N/A 2030-12-07 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 77,580 | $0 | 79,850 (Direct) | View |
| 2020-06-30 Option Award | 2020-12-09 8:52 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 1,245 | $17.07 | 79,850 (Direct) | View |
| 2019-12-31 Option Award | 2020-01-03 6:15 pm | N/A N/A | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 1,025 | $18.87 | 1,025 (Direct) | View |
| 2019-12-13 Option Award | 2019-12-13 9:07 pm | N/A 2029-12-12 | Akero Therapeutics Inc. | AKRO | White William Richard Chief Financial Officer | 85,000 | $0 | 85,000 (Direct) | View |
Ownership | 2019-06-19 6:31 pm | N/A 2029-04-04 | Akero Therapeutics Inc. | AKRO | White William Richard EVP, Chief Financial Officer | 0 | $0 | 414,029 (Direct) | View |